Anastasiia Karnaukhova

SD, Head Global Program Management N&I, Fertility, CME, GH | R&D Strategy, Portfolio & Hubs

Merck Group

Darmstadt, Germany

6 profile visitsSpeakerSpeaker

Leading Global Program Management at Merck, I drive innovation across multiple therapeutic areas, fostering collaboration and excellence in drug development.

My organisation

About me

As the leader of Global Program Management at Merck Healthcare, with my dynamic team we advance our pipeline across various therapeutic areas, including Neuroscience & Immunology, Fertility, CM&E, and Global Health.
With a strong foundation in strategic leadership, I foster a state-of-the-art GPM organization that champions innovation and embraces diversity, empowering cross-functional collaboration to meet patients' urgent needs for novel treatments.
My journey spans big pharma, biotech, and mid-sized companies, where I have held local and global roles, enriching my expertise in diverse treatment areas. At MorphoSys, I spearheaded R&D Operations & Excellence, ensuring effective drug development strategy execution that led to the successful delivery of innovative cancer therapies, including tafasitamab for DLBCL patients and Pelabresib for MF.
My commitment to excellence in drug development is driven by a passion for addressing unmet medical needs, making a tangible impact in patients' lives.

Social media

Speaker sessions (2)

Thursday, 3 April 2025

13:30 - 14:00

CASE STUDY: Global Program Management (GPM) Evolution: Key to Transforming Global Program Team (GPT) Operating Model

Location:VIA BaselTrack:29th European Biopharma Project Program and Portfolio Management

14:00 - 14:40

PANEL DISCUSSION: Customizing Project Management Strategies for Biopharma Success—Key Lessons from Small and Large Companies

Location:VIA BaselTrack:29th European Biopharma Project Program and Portfolio Management